产品名称
Mobius Gold High Cell Density Cryopreservation Assembly, (-80C), 100mL, sterile; γ-irradiated (at 25-40 kGy)
material
C-Flex® tubing (374)
device (thermoplastic elastomer)
polyethylene device
polypropylene device
silicone device
tubing (Pharma 65)
agency
according to ISO 11137
meets EN 2.6.14
meets JP 4.01
meets USP 85
sterility
sterile; γ-irradiated (level of 25-40 kGy)
product line
Mobius®
packaging
package of 5 ×
parameter
-80-60 °C temp. range (-112-140 °F)
0.3 bar max. pressure (4.4 psi)
60 mL process volume
technique(s)
buffer exchange: suitable
media fill: suitable
capacity
100 mL
impurities
<0.25 EU/mL Aqueous extraction (LAL test)
fitting
plug (plug-end 1/8"HB)
port (end-ported 2x 1/8"HB)
application(s)
cell therapy
gene therapy
life science and biopharma
liquid processing
mAb
ophthalmics
parenterals
pharma/biopharma processes
viral therapy
waste management
storage temp.
2-30°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
Biochem/physiol Actions
Application
General description
Our Mobius® High Cell Density Cryopreservation (HCDC) Assembly (-196C) is a single-use assembly specially designed to facilitate the freeze and thaw of cryopreserved cells in liquid nitrogen vapor phase (? -196°C). Available in two assembly bag sizes of 100 mL and 250 mL, our Mobius® HCDC Assembly (-196C) enables seed train inoculation with cells at a higher cell density and larger volume compared to the traditional seed train process using vials, which significantly accelerates the cell expansion process. Our Mobius® single-use assembly also provides a closed processing environment preventing contamination while improving process reproducibility.
Other Notes
Pinch clamp: Nylon
Packaging
Legal Information
法规信息
商品
Understand how considerations such as DMSO concentrations and freezing techniques are key in the successful implementation of high cell density cryopreservation (HCDC).
High cell density cryopreservation (HCDC) is a closed processing alternative to the traditional seed train expansion process. Learn more about the benefits of HCDC.
How the Cellicon® filter and controller enables seamless adoption of a perfused N-1 seed train step into the cell expansion process.
This article explains how to streamline transfer of an allogeneic cell therapies process to a CDMO partner and long-term manufacturing success.
相关内容
Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.
Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.
Learn more about cell culture media development for mAB development and manufacturing, and the products you need for this step.
生物制药开发商需要高效、高产的上游工艺来提供优质的单克隆抗体(mAb)和其他类型重组蛋白。工艺强化可确保生产策略适应未来发展需求、降低成本并提升设施灵活性。
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持